TG Therapeutics granted Orphan Drug Designation for Ublituximab

|About: TG Therapeutics, Inc. (TGTX)|By:, SA News Editor

TG Therapeutics (TGTX +3.8%) pops after being granted an Orphan Drug Designation for Ublituximab, a treatment for extranodal marginal zone lymphoma.